BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 9636875)

  • 1. Rhinocerebral mucormycosis treated with amphotericin B colloidal dispersion in three patients.
    Moses AE; Rahav G; Barenholz Y; Elidan J; Azaz B; Gillis S; Brickman M; Polacheck I; Shapiro M
    Clin Infect Dis; 1998 Jun; 26(6):1430-3. PubMed ID: 9636875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rhinocerebral mucormycosis. Therapy with amphotericin B lipid complex.
    Strasser MD; Kennedy RJ; Adam RD
    Arch Intern Med; 1996 Feb; 156(3):337-9. PubMed ID: 8572846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endoscopic management of rhinocerebral mucormycosis with topical and intravenous amphotericin B.
    Saedi B; Sadeghi M; Seilani P
    J Laryngol Otol; 2011 Aug; 125(8):807-10. PubMed ID: 21729440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of rhinocerebral mucormycosis by combination of endoscopic sinus debridement and amphotericin B.
    Alobid I; Bernal M; Calvo C; Vilaseca I; Berenguer J; Alós L
    Am J Rhinol; 2001; 15(5):327-31. PubMed ID: 11732820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paranasal sinus mucormycosis in an immunocompetent host: efficacy and safety of combination therapy with Liposomal Amphotericin B and adjuvant rHuGM-CSF.
    Mastroianni A
    Infez Med; 2004 Dec; 12(4):278-83. PubMed ID: 15729020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of 21 cases of invasive mucormycosis with amphotericin B colloidal dispersion.
    Herbrecht R; Letscher-Bru V; Bowden RA; Kusne S; Anaissie EJ; Graybill JR; Noskin GA; Oppenheim ; Andrès E; Pietrelli LA
    Eur J Clin Microbiol Infect Dis; 2001 Jul; 20(7):460-6. PubMed ID: 11561801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rhinocerebral mucormycosis diagnosis by aspiration cytology.
    Deshpande AH; Munshi MM
    Diagn Cytopathol; 2000 Aug; 23(2):97-100. PubMed ID: 10888753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term survival in rhinocerebral mucormycosis. Case report.
    Weprin BE; Hall WA; Goodman J; Adams GL
    J Neurosurg; 1998 Mar; 88(3):570-5. PubMed ID: 9488314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraconal amphotericin B for the treatment of rhino-orbital mucormycosis.
    Luna JD; Ponssa XS; Rodríguez SD; Luna NC; Juárez CP
    Ophthalmic Surg Lasers; 1996 Aug; 27(8):706-8. PubMed ID: 8858637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful treatment of rhinocerebral mucormycosis by a combination of aggressive surgical debridement and the use of systemic liposomal amphotericin B and local therapy with nebulized amphotericin--a case report.
    Raj P; Vella EJ; Bickerton RC
    J Laryngol Otol; 1998 Apr; 112(4):367-70. PubMed ID: 9659500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amphotericin B colloidal dispersion.
    Patel R
    Expert Opin Pharmacother; 2000 Mar; 1(3):475-88. PubMed ID: 11249532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rhinocerebral mucormycosis in the era of lipid-based amphotericin B: case report and literature review.
    Mondy KE; Haughey B; Custer PL; Wippold FJ; Ritchie DJ; Mundy LM
    Pharmacotherapy; 2002 Apr; 22(4):519-26. PubMed ID: 11939688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of amphotericin B colloidal dispersion.
    Herbrecht R
    Eur J Clin Microbiol Infect Dis; 1997 Jan; 16(1):74-80. PubMed ID: 9063677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liposomal amphotericin B treatment for rhinocerebral mucormycosis: how much is enough?
    Handzel O; Landau Z; Halperin D
    Rhinology; 2003 Sep; 41(3):184-6. PubMed ID: 14579660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of posaconazole in the treatment of infective rhinocerebral mucormycosis.
    Kulendra K; Habibi M; Butler C; Clarke P; Howard D
    J Laryngol Otol; 2010 Dec; 124(12):1314-7. PubMed ID: 20388246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful treatment of zygomycosis of the paranasal sinuses with surgical debridement and amphotericin B colloidal dispersion.
    Tkatch LS; Kusne S; Eibling D
    Am J Otolaryngol; 1993; 14(4):249-53. PubMed ID: 8214317
    [No Abstract]   [Full Text] [Related]  

  • 17. Successful treatment of rhinocerebral mucormycosis with liposomal amphotericin B and surgery in two diabetic patients with renal dysfunction.
    Kofteridis DP; Karabekios S; Panagiotides JG; Bizakis J; Kyrmizakis D; Saridaki Z; Gikas A
    J Chemother; 2003 Jun; 15(3):282-6. PubMed ID: 12868556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rhinocerebral zygomycosis treated with liposomal amphotericin B and surgery.
    Saltoğlu N; Taşova Y; Zorludemir S; Dündar IH
    Mycoses; 1998; 41(1-2):45-9. PubMed ID: 9610133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An unusual presentation of rhinofacial zygomycosis due to Cunninghamella sp. in an immunocompetent patient: a case report and literature review.
    Jayasuriya NS; Tilakaratne WM; Amaratunga EA; Ekanayake MK
    Oral Dis; 2006 Jan; 12(1):67-9. PubMed ID: 16390472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rhinocerebral mucormycosis in a boy with recurrent acute lymphoblastic leukemia: long-term survival with systemic antifungal treatment.
    Wehl G; Hoegler W; Kropshofer G; Meister B; Fink FM; Heitger A
    J Pediatr Hematol Oncol; 2002; 24(6):492-4. PubMed ID: 12218600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.